Activity value 75india Supplier,Last transaction date:
2026-06-09
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for navkar pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 22 transactions, with a transaction quantity of 617 and a transaction weight of 0.
YearTransactionsQuantityWeight
20255068850
2026226170
Bill of lading data
<
1/15
>
Trade date
2026/06/09
B/L No.
——
Suppliers
navkar pharma
Buyers
pearl pharmaceuticals
POLs
——
PODs
ipaf
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
906.963708
Hs code
29341090
Product tags
famotidine,pharmaceutical raw material
Product description
PHARMACEUTICAL RAW MATERIAL FAMOTIDINE
Expand
Trade date
2026/05/14
B/L No.
——
Suppliers
navkar pharma
Buyers
ms biogen pharma
POLs
——
PODs
ipaf
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
2146.056363
Hs code
29335990
Product tags
clozapine,pharmaceutical raw material
Product description
PHARMACEUTICAL RAW MATERIAL CLOZAPINE USP
Expand
Trade date
2026/05/14
B/L No.
——
Suppliers
navkar pharma
Buyers
ms biogen pharma
POLs
——
PODs
ipaf
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
1149.671513
Hs code
29214900
Product tags
pharmaceutical raw material,sertraline hcl
Product description
PHARMACEUTICAL RAW MATERIAL SERTRALINE HCL USP
Expand
Product description
PHARMACEUTICAL RAW MATERIAL ( FAMOTIDINE ) USP ...IN POWDER FORM ...BATCH NO FAM-0126001...MFG DATE 01-2026...EXPIRY DATE 12.2030...QUANTITY 01 DRUM ...NET WEIGHT 25 KGS ...BRAND NAVKAR PHARMA ...I/O AND SHIPMENT FROM INDIA
Expand
Product description
PHARMACEUTICAL RAW MATERIAL ( TIZANIDINE HCL ) IN POWDER FORM ...BATCH NO VTZD25003...MFG DATE 09.2025...EXPIRY DATE 08.2030...QUANTITY 01 DRUM ...NET WEIGHT 1 KG...BRAND NAVKAR PHARMA ...I/O AND SHIPMENT FROM INDIA
Expand
Trade date
2026/02/12
B/L No.
8757754
Suppliers
navkar pharma
Buyers
b ank al habib ltd.
POLs
mumbai (ex bombay)
PODs
lahore
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
64552.34
Hs code
29332990
Product tags
pharmaceutical,ondansetron hcl,march,opa,raw material
Product description
PHARMACEUTICAL ALLOPATHIC RAW MATERIALONDANSETRON HCL USP B N ONH N 25 001MFG DT MARCH 2026 EXP DT FEB 2030
Expand
Trade date
2026/02/12
B/L No.
7164375
Suppliers
navkar pharma
Buyers
b ank al habib ltd.
navkar pharma is india Supplier,
and primarily engages in the import and export business of products such as raw material,bat,pharmaceutical.
According to the 52wmb.com global trade database, as of 2026-06-09, the company has completed 410 international trades,
with its main trading regions covering pakistan,the democratic republic of the congo,afghanistan etc.
The core products include HS29333990,HS29349990,HS29359090 etc,
often transported via sahar air cargo acc inbom4,port bombay air, port mumbai (ex bombay) etc,
and its main trading partners are b ank al habib ltd.,meezan bank,magnus sarl.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on navkar pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.